journal article·2023-07Open access

Permanent Anticoagulation Blood‐Vessel by Mezzo‐Sized Double Re‐Entrant Structure

Dongkwon Seo, Yang Hyun Cho, Gijung Kim, Hyunku Shin, Su Kyoung Lee, Ji Eon Kim, Honggu Chun, Jae Seung Jung, Yeonho Choi

Small· Volume 19· Issue 27

Abstract

Abstract Having a permanent omniphobicity on the inner surface of the tube can bring enormous advantages, such as reducing resistance and avoiding precipitation during mass transfer. For example, such a tube can prevent blood clotting when delivering blood composed of complex hydrophilic and lipophilic compounds. However, it is very challenging to fabricate micro and nanostructures inside a tube. To overcome these, a wearability and deformation‐free structural omniphobic surface is fabricated. The omniphobic surface can repel liquids by its “air‐spring” under the structure, regardless of surface tension. Furthermore, it is not lost an omniphobicity under physical deformation like curved or twisted. By using these properties, omniphobic structures on the inner wall of the tube by the “roll‐up” method are fabricated. Fabricated omniphobic tubes still repels liquids, even complex liquids like blood. According to the ex vivo blood tests for medical usage, the tube can reduce thrombus formation by 99%, like the heparin‐coated tube. So, the surface will soon replace typical coating‐based medical surfaces or anticoagulation blood vessels.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Surface Modification and Superhydrophobicity · Electrospun Nanofibers in Biomedical Applications · Polymer Surface Interaction Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bio‐Convergence Engineering Korea University Seoul 02841 Republic of Korea

Interdisciplinary Program in Precision Public Health Korea University Seoul 02841 Republic of Korea

Department of Thoracic and Cardiovascular Surgery Samsung Medical Center Seoul 06351 Republic of Korea

Exopert Corporation Seoul 02841 Republic of Korea

Korea Artificial Organ Center Seoul 02841 Republic of Korea

Department of Thoracic and Cardiovascular Surgery College of Medicine Korea University Seoul 02841 Republic of Korea

School of Biomedical Engineering Korea University Seoul 02841 Republic of Korea

Funding

National Research Foundation

References (57)

Show source-provided references
1. 10.1002/adma.20100312910.1002/adma.201003129 ↗
2. 10.1016/j.mattod.2015.01.00110.1016/j.mattod.2015.01.001 ↗
3. 10.1021/cr400083y10.1021/cr400083y ↗
4. 10.1021/acsnano.8b0509910.1021/acsnano.8b05099 ↗
5. 10.1002/ange.20190421010.1002/ange.201904210 ↗
6. 10.1021/acsami.0c2315110.1021/acsami.0c23151 ↗
7. 10.1039/c3sm50445j10.1039/c3sm50445j ↗
8. 10.1039/C4CC02775B10.1039/C4CC02775B ↗
9. 10.1038/nbt.302010.1038/nbt.3020 ↗
10. 10.1021/acsami.5b0788110.1021/acsami.5b07881 ↗
11. 10.1021/acsami.6b0019410.1021/acsami.6b00194 ↗
12. 10.1021/acsnano.7b0004610.1021/acsnano.7b00046 ↗
13. 10.1021/acsami.9b1749410.1021/acsami.9b17494 ↗
14. 10.1039/C3NR04755E10.1039/C3NR04755E ↗
15. 10.3390/molecules1904425610.3390/molecules19044256 ↗
16. 10.1002/admi.20160028910.1002/admi.201600289 ↗
17. 10.1098/rsif.2014.028710.1098/rsif.2014.0287 ↗
18. 10.1038/am.2012.6610.1038/am.2012.66 ↗
19. 10.1021/jp407039910.1021/jp4070399 ↗
20. 10.1002/adma.20120469610.1002/adma.201204696 ↗
21. 10.1021/la304179b10.1021/la304179b ↗
22. 10.1002/adma.20130540810.1002/adma.201305408 ↗
23. 10.1039/C5CS00438A10.1039/C5CS00438A ↗
24. 10.1002/adma.20150364310.1002/adma.201503643 ↗
25. 10.1021/acs.langmuir.6b0375210.1021/acs.langmuir.6b03752 ↗
26. 10.1021/acsami.8b2052110.1021/acsami.8b20521 ↗
27. 10.1002/admi.20190215910.1002/admi.201902159 ↗
28. 10.1126/science.114832610.1126/science.1148326 ↗
29. 10.1002/adma.20130208310.1002/adma.201302083 ↗
30. 10.1002/anie.20130722210.1002/anie.201307222 ↗
31. 10.1021/nl501767j10.1021/nl501767j ↗
32. 10.1098/rsif.2014.061910.1098/rsif.2014.0619 ↗
33. 10.1002/adfm.20190938910.1002/adfm.201909389 ↗
34. 10.1038/s41467-019-11209-610.1038/s41467-019-11209-6 ↗
35. 10.1002/adfm.20190268610.1002/adfm.201902686 ↗
36. 10.1002/adma.20190141710.1002/adma.201901417 ↗
37. 10.1002/adfm.20210746510.1002/adfm.202107465 ↗
38. 10.1098/rstl.1805.000510.1098/rstl.1805.0005 ↗
39. 10.1039/tf944400054610.1039/tf9444000546 ↗
40. 10.1021/ie50320a02410.1021/ie50320a024 ↗
41. 10.1002/adma.20120255410.1002/adma.201202554 ↗
42. 10.1021/cr400169m10.1021/cr400169m ↗
43. 10.1039/C3NR04629J10.1039/C3NR04629J ↗
44. 10.1039/C4NR04069D10.1039/C4NR04069D ↗
45. 10.1021/am508606610.1021/am5086066 ↗
46. 10.1002/admi.20150007110.1002/admi.201500071 ↗
47. 10.1002/adma.20160248010.1002/adma.201602480 ↗
48. 10.1021/acs.langmuir.6b0375210.1021/acs.langmuir.6b03752 ↗
49. 10.1039/C6TA11133E10.1039/C6TA11133E ↗
50. 10.1039/C7TA04073C10.1039/C7TA04073C ↗
51. 10.1021/acsami.7b0352610.1021/acsami.7b03526 ↗
52. 10.1038/ncomms1582310.1038/ncomms15823 ↗
53. 10.1002/adma.20170383810.1002/adma.201703838 ↗
54. 10.1016/S1001-6058(09)60066-410.1016/S1001-6058(09)60066-4 ↗
55. 10.1504/IJOGCT.2012.04631810.1504/IJOGCT.2012.046318 ↗
56. 10.1063/1.488065610.1063/1.4880656 ↗
57. 10.1021/acs.langmuir.5b0035310.1021/acs.langmuir.5b00353 ↗